In addition, the results uncovered that the expression of ADAM17 was positively correlated with an immunostimulator (IL6R) (Figure 7B) and immunoinhibitors (CD274, KDR, TGFBR1) (Figure 7C) in most cancer types. The gene discussed is TGFBR1; the disease is cancer.